Servicio de Información Comunitario sobre Investigación y Desarrollo - CORDIS

CORDIS reúne toda la información sobre los proyectos financiados por Horizonte 2020 , y ahora también resúmenes de los informes relacionados. Se puede descargar toda la documentación de estos proyectos en el Portal de datos abiertos de la UE .

My refinements

Download results of this page

Restringir por:

Advanced search

Búsqueda de proyectos y resultados

Results 1 - 10 of 18
12 > 
European Human Biomonitoring Initiative
ID: 733032
Fecha de inicio: 2017-01-01, Fecha de finalización: 2021-12-31
The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts...
Programme: H2020-EU.3.1.2.
Record Number: 207219
Last updated on: 2017-05-23
Periodic Reporting for period 1 - ENSAT-HT (Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension)
Arterial hypertension affects up to 45% of the general population and is responsible for 7.1 million deaths per year worldwide. However, optimal blood pressure control is not being achieved in up to two thirds of patients. Endocrine forms (E) of high (H) blood pressure (BP...
Programme: H2020-EU.3.1.2.
Record Number: 198109
Last updated on: 2017-05-16
Periodic Reporting for period 1 - EUthyroid (Towards the elimination of iodine deficiency and preventable thyroid-related diseases in Europe)
Iodine deficiency is the world’s leading cause of preventable brain damage and for years the World Health Organization has warned that Europeans are increasingly affected by the consequences of iodine deficiency. Europe currently has no harmonised approach to ensure that the...
Programme: H2020-EU.3.1.2.
Record Number: 198275
Last updated on: 2017-05-18
Periodic Reporting for period 1 - SCOPE (Screening for Chronic Kidney Disease (CKD)  among Older People across Europe (SCOPE))
What is the problem/issue being addressed?Although Chronic kidney disease (CKD) prevalence is increasing, screening programme in Europe are highly heterogeneous, fragmented, being in most cases based on opportunistic rather than structured assessments of patients. Such...
Programme: H2020-EU.3.1.2.
Record Number: 195236
Last updated on: 2017-02-23
Developing a Chlamydia Trachomatis vaccine
ID: 733373
Fecha de inicio: 2017-03-01, Fecha de finalización: 2021-02-28
The TRACVAC Consortium will eliminate the global problem of blinding trachoma through the development of a vaccine. Our strategy of the project will eliminate two important bottlenecks for the development of a trachoma vaccine 1) The lack of neutralizing antibody responses to...
Programme: H2020-EU.3.1.2.
Record Number: 208491
Last updated on: 2017-03-01
Crimean-Congo Haemorrhagic Fever Vaccine
[PROYECTO] CCHFVaccine - Crimean-Congo Haemorrhagic Fever Vaccine
ID: 732732
Fecha de inicio: 2017-01-01, Fecha de finalización: 2022-12-31
Natural epidemics and outbreaks of emerging viral epidemics are growing problems internationally. The general aim of the CCHFVaccine project is to develop and deliver a vaccine, which can significantly increase our capacity to control the situation of Crimean Congo...
Programme: H2020-EU.3.1.2.
Record Number: 207211
Last updated on: 2017-05-18
Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria
ID: 733073
Fecha de inicio: 2017-01-01, Fecha de finalización: 2021-12-31
Plasmodium vivax is the most widespread malaria and constitutes a significant proportion of human malaria cases. P. vivax accounts for 100-400 million clinical cases each year among the 2.5 billion people living at risk in Latin America, Oceania and Asia. The recently revised...
Programme: H2020-EU.3.1.2.
Record Number: 207218
Last updated on: 2017-04-19
Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine
ID: 733176
Fecha de inicio: 2017-01-01, Fecha de finalización: 2020-12-31
Rabies is the deadliest disease on earth (99.9% fatality rate). Annually, ~58.000 people die from rabies, more than half of them are children. Many remain unvaccinated because of the high costs and the need for a cold-chain. Likewise, despite the existence of an excellent...
Programme: H2020-EU.3.1.2.
Record Number: 207222
Last updated on: 2016-12-02
Fast track development of a Zika vaccine based on measles vector
ID: 732432
Fecha de inicio: 2016-10-01, Fecha de finalización: 2020-09-30
Zika virus is an emerging mosquito-borne flavivirus. Although already isolated in 1947, to date there are no specific treatments nor any vaccines available against Zika virus disease, making it a truly neglected infectious disease. The recent rapid spread of the Zika virus in...
Programme: H2020-EU.3.1.2.
Record Number: 207210
Last updated on: 2017-03-07
Optimizing a deployable high efficacy malaria vaccine
ID: 733273
Fecha de inicio: 2017-01-01, Fecha de finalización: 2021-12-31
A highly effective malaria vaccine against Plasmodium falciparum should help prevent half a million deaths from malaria each year. New vaccine technologies and antigen discovery approaches now make accelerated design and development of a highly effective multi-antigen...
Programme: H2020-EU.3.1.2.
Record Number: 207225
Last updated on: 2017-04-19
12 > 
List retrieved on: 2017-06-22